跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADRIAMYCIN doxorubicin hydrochloride 20mg/10mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
ADRIAMYCIN doxorubicin hydrochloride 20mg/10mL injection vial
Approved
STANDARD
ADRIAMYCIN doxorubicin hydrochloride 20mg/10mL injection vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
8d0e56cc59ec9993
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
8d0e56cc59ec9993
Product Name
ADRIAMYCIN doxorubicin hydrochloride 20mg/10mL injection vial
Artg Id
47344
Artg Name
ADRIAMYCIN doxorubicin hydrochloride 20mg/10mL injection vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1993-12-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/02bc68e65461c76d703b141b0a071eed.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
8d0e56cc59ec9993
Type
Standard
Back to TGA Approvals